Carmignac Gestion’s ChemoCentryx, Inc. CCXI Stock Holding History

Carmignac Gestion’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Hold	0	–	-$1.48M	–	146
2021 Q2	–	Hold	0	–	–	–	118

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Carmignac Gestion's CCXI Position: Q2 2021 in Review

Carmignac Gestion sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 53,465 shares — an estimated $1.32M sold.

Carmignac Gestion first reported a position in CCXI in Q1 2018 and held it in 13 quarters. The position peaked at $27.3M in Q1 2019. 147 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Carmignac Gestion reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Carmignac Gestion sold 53,465 ChemoCentryx, Inc. shares in Q2 2021, an estimated $1.32M.
Carmignac Gestion first reported a position in ChemoCentryx, Inc. in Q1 2018 and held it in 13 quarters.
Carmignac Gestion's ChemoCentryx, Inc. position peaked at $27.3M in Q1 2019.
147 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Carmignac Gestion's 13F filing for Q2 2021, filed 13 Aug 2021.